Correction Notice on a Study About Lung Cancer Drug Costs

The Italian research team has released an update to their earlier work that examined how affordable the drug osimertinib is for patients with a specific type of lung cancer. The original paper, published in the December 2025 issue of ESMO Real World Data and Digital Oncology, used real‑world patient